In Brief: FDA reform
This article was originally published in The Tan Sheet
Executive Summary
FDA reform: Senate Labor Committee Chairman James Jeffords (R-Vt.) reiterates request for Administration's legislative proposals, stating in an April 18 letter to HHS Secretary Donna Shalala: "I am deeply concerned that we will be forced to act [on user fee legislation reauthorization and FDA reform] without the input of the FDA." Jeffords' office indicates that the agency did not meet the senator's April 25 deadline for submission of a proposal. FDA did participate in a staff-level meeting on April 25 at the committee's request and is said to be in the process of developing legislative language. Jeffords writes that he intends to have legislation linking user fees and FDA "improvements" ready for May committee mark-up...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning